Page last updated: 2024-08-17

penicillanic acid and Bewilderment

penicillanic acid has been researched along with Bewilderment in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
El-Ibiary, S; Gorlitsky, B1
Kwan, TH; Siu, YP; Tong, MK; Yung, CY1
Capparelli, FJ; Del Castillo, ME; Diaz, MF; Hlavnika, A; Leiguarda, R; Wainsztein, NA1

Other Studies

3 other study(ies) available for penicillanic acid and Bewilderment

ArticleYear
A Common But Not so Typical Elevated Anion Gap.
    The American journal of medicine, 2016, Volume: 129, Issue:5

    Topics: Acetone; Acidosis; Adult; Anti-Bacterial Agents; Blood Glucose; Confusion; Diabetes Complications; Fever; Fluid Therapy; Humans; Leg Injuries; Male; Methicillin-Resistant Staphylococcus aureus; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Sodium Bicarbonate; Staphylococcal Infections; Vancomycin

2016
Piperacillin/tazobactam-induced acute delirium in a peritoneal dialysis patient.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2004, Volume: 19, Issue:5

    Topics: Anti-Bacterial Agents; Bacterial Infections; Confusion; Delirium; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Hallucinations; Humans; Kidney Failure, Chronic; Male; Middle Aged; Penicillanic Acid; Peritoneal Dialysis, Continuous Ambulatory; Piperacillin; Tazobactam

2004
Cefepime- and cefixime-induced encephalopathy in a patient with normal renal function.
    Neurology, 2005, Dec-13, Volume: 65, Issue:11

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Brain; Cefepime; Cefixime; Cephalosporins; Confusion; Consciousness Disorders; Delirium; Epididymitis; Humans; Kidney; Male; Metabolic Clearance Rate; Neurotoxicity Syndromes; Penicillanic Acid; Piperacillin; Recovery of Function; Secondary Prevention; Systemic Inflammatory Response Syndrome; Tazobactam; Urinary Tract Infections; Withholding Treatment

2005